erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
the uk�s initial plan had been challenged in court by the..
``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''